New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Wave Life Sciences Ltd.
Wave Life Sciences Ltd.
Industry: Life Sciences ・ $WVE on Nasdaq ・ Market Cap: Small
CEO Recent Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
TRADES PURCHASE/SALE Sector Average | 3 / 5 2.19 / 7.65 |
INSIDER BUYERS/SELLERS Sector Average | 2 / 3 1.2 / 2.5 |
SHARES PURCHASED/SOLD Transaction Average | 7,091,930 / 380,452 2,363,977 / 76,090 |
VALUE PURCHASED/SOLD Transaction Average | $43,835,440 / $4,719,233 $14,611,813 / $943,847 |
PURCHASE RANGE | $5,000,000 - $22,335,440 |
SALE RANGE | $96,437.1 - $2,831,816.16 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
14.1%
DIRECTORS
0%
OFFICERS
85.9%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.386 0.2 |
VALUE GINI INDEX Sector Average | 0.359 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
36.49%
DIRECTORS
63.51%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.365 0.295 |
VALUE GINI INDEX Sector Average | 0.309 0.288 |
Wave Life Sciences Ltd. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
---|---|---|---|---|---|---|---|---|---|---|
2024-11-15 2024-11-15 | BOLNO PAUL | Director | -$733,671 | 51,234 | $14.32 | -19.08% | 217,351 | N/A | N/A | |
2024-11-13 2024-11-08 | Francis Chris | Officer | -$576,000 | 36,000 | $16 | -100% | 0 | N/A | N/A | |
2024-10-18 2024-10-16 | Francis Chris | Officer | -$2,831,816 | 208,836 | $13.56 | -100% | 0 | N/A | N/A | |
2024-10-18 2024-10-16 | BOLNO PAUL | Director | -$1,357,110 | 90,474 | $15 | -25.2% | 268,585 | N/A | N/A | |
2024-10-01 2024-09-27 | GLAXOSMITHKLINE PLC | 10% Owner | +$22,335,440 | 2,791,930 | $8 | +19.97% | 16,775,691 | +1.69% | +1.69% | |
2024-09-27 2024-09-25 | Moran Kyle | Officer | -$154,314 | 17,146 | $9 | -46.44% | 19,777 | -2.73% | +0.12% | |
2024-08-23 2024-08-21 | BOLNO PAUL | Director | -$279,555 | 48,366 | $5.78 | -11.87% | 359,059 | +0.52% | 0.00% | |
2024-04-05 2024-04-03 | Moran Kyle | Officer | -$96,437 | 15,630 | $6.17 | -31.54% | 33,921 | -1.86% | -1.86% | |
2024-01-30 2023-12-07 | GLAXOSMITHKLINE PLC | 10% Owner | +$16,500,000 | 3,300,000 | $5 | +30.89% | 13,983,761 | +0.23% | -5.80% | |
2023-12-13 2023-12-11 | RA CAPITAL MANAGEMENT, L.P. | Director | +$5,000,000 | 1,000,000 | $5 | +5.49% | 19,202,009 | -1.51% | +3.67% |